Overview

The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including midwives, nurses, general medical practitioners, obstetricians, obstetric physicians, managers of maternal and child health programmes, and relevant staff in ministries of health, in all settings.

Contents

• Acknowledgements
• Acronyms and abbreviations
• Executive Summary
  • Introduction
  • Target audience
  • Guideline development methods
  • Recommendations
• 1. Background
  • Rationale and objectives
  • Target audience
  • Scope of the recommendations
  • Persons affected by the recommendations
• 2. Methods
  • Contributors to the guideline
  • Identification of critical outcomes
  • Evidence identification and retrieval
  • Certainty assessment and grading of the evidence
  • Formulation of recommendations
  • Management of declaration of interests
  • Decision-making during the GDG meeting
  • Document preparation
  • Peer review
• 3. Recommendations and supporting evidence
• 4. Dissemination and implementation of the recommendations
  • Dissemination and evaluation
  • Implementation considerations
• 5. Research implications
• 6. Applicability issues
  • Anticipated impact on the organization of care and resources
  • Monitoring and evaluating guideline implementation
• 7. Updating the recommendations
• Annex 1. External experts and WHO staff involved in the preparation of the guideline
• Annex 2. Priority outcomes for decision-making
• Annex 3. Summary and management of declared interests from GDG and External Review Group members
• Annex 4. Evidence-to-decision framework
• References
• GRADE tables

Suggested citation:

WHO recommendations on drug treatment for non-severe hypertension in pregnancy. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.

General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.